Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: Fast-acting treatment of myasthenic crisis with efgartigimod from the perspective of the neonatal intensive care unit

Fig. 1

Treatment descriptions for case 1 (A), case 2 (B), case 3 (C), case 4 (D) and case5 (E). The figure illustrates a timeline depicting the entire process for five MC patients, encompassing the stages of diagnosis, treatment, and subsequent recovery. The purple markers indicate the timing and frequency of efgartigimod infusions. Additionally, changes in treatment are depicted along the trajectory. MG = myasthenia gravis; IVMP = intravenous high-dose methylprednisolone; IVIG = intravenous immunoglobulin

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us